These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24641716)

  • 1. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.
    Kim JE; Jeon JS
    Neurol Res; 2014 May; 36(5):407-16. PubMed ID: 24641716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in hemorrhagic moyamoya disease.
    Wan M; Duan L
    Br J Neurosurg; 2015 Apr; 29(2):189-91. PubMed ID: 25365664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya disease in children.
    Takanashi J
    Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
    Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
    J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature.
    Lee SC; Jeon JS; Kim JE; Chung YS; Ahn JH; Cho WS; Son YJ; Bang JS; Kang HS; Oh CW
    Acta Neurochir (Wien); 2014 Jan; 156(1):103-11. PubMed ID: 24201757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide survey on unilateral moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya Disease.
    Fujimura M; Bang OY; Kim JS
    Front Neurol Neurosci; 2016; 40():204-220. PubMed ID: 27960175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of unilateral moyamoya disease: A clinical series.
    Kelly ME; Bell-Stephens TE; Marks MP; Do HM; Steinberg GK
    Cerebrovasc Dis; 2006; 22(2-3):109-15. PubMed ID: 16685122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study.
    Yamamoto S; Koh M; Kashiwazaki D; Akioka N; Kuwayama N; Noguchi K; Kuroda S
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1509-16. PubMed ID: 27038981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution magnetic resonance wall imaging findings of Moyamoya disease.
    Ryoo S; Cha J; Kim SJ; Choi JW; Ki CS; Kim KH; Jeon P; Kim JS; Hong SC; Bang OY
    Stroke; 2014 Aug; 45(8):2457-60. PubMed ID: 24947295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
    Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.
    Ishimori ML; Cohen SN; Hallegua DS; Moser FG; Weisman MH
    Semin Arthritis Rheum; 2006 Feb; 35(4):250-9. PubMed ID: 16461070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.
    Yu LB; He H; Zhao JZ; Wang R; Zhang Q; Shi ZY; Shao JS; Zhang D
    World Neurosurg; 2016 Dec; 96():252-260. PubMed ID: 27576769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.